| Pomalidomide Rowex 3 mg hard capsules PA0711/338/003 |
Pomalidomide |
Rowex Limited, |
Marketed |
| Pomalidomide Rowex 4 mg hard capsules PA0711/338/004 |
Pomalidomide |
Rowex Limited, |
Marketed |
| Pomalidomide Teva 1 mg Capsule, hard EU/1/24/1868/001-012 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Teva 2 mg Capsule, hard EU/1/24/1868/013-024 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Teva 3 mg Capsule, hard EU/1/24/1868/025-036 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Teva 4 mg Capsule, hard EU/1/24/1868/037-048 |
Pomalidomide |
TEVA GmbH |
— |
| Pomalidomide Viatris 1 mg hard capsules EU/1/23/1785/001-004 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Viatris 2 mg hard capsules EU/1/23/1785/005-008 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Viatris 3 mg hard capsules EU/1/23/1785/009-012 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Viatris 4 mg hard capsules EU/1/23/1785/013-016 |
Pomalidomide |
Viatris Limited |
— |
| Pomalidomide Zentiva 1 mg hard capsules EU/1/24/1830/001-004 |
Pomalidomide |
Zentiva k.s. |
— |
| Pomalidomide Zentiva 2 mg hard capsules EU/1/24/1830/005-008 |
Pomalidomide |
Zentiva k.s. |
— |
| Pomalidomide Zentiva 3 mg hard capsules EU/1/24/1830/009-012 |
Pomalidomide |
Zentiva k.s. |
— |
| Pomalidomide Zentiva 4 mg hard capsules EU/1/24/1830/013-016 |
Pomalidomide |
Zentiva k.s. |
— |
| Pombiliti 105 mg powder for concentrate for solution for infusion EU/1/22/1714/001-003 |
Cipaglucosidase alfa |
Amicus Therapeutics Europe Limited |
— |
| Ponlimsi 60 mg solution for injection in pre-filled syringe EU/1/25/1986/001 |
Denosumab |
TEVA GmbH |
— |
| Ponstan 250 mg Capsules PA22643/001/001 |
Mefenamic acid |
Chemidex Pharma Limited |
Marketed |
| Ponstan 500 mg capsules PA22643/001/003 |
Mefenamic acid |
Chemidex Pharma Limited |
Not marketed |
| Ponstan Forte 500 mg Film-coated Tablets PA22643/001/002 |
Mefenamic acid |
Chemidex Pharma Limited |
Marketed |
| Ponvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tablets EU/1/21/1550/001 |
Ponesimod |
Laboratoires Juvise Pharmaceuticals |
— |
| Ponvory 20 mg film-coated tablets EU/1/21/1550/002 |
Ponesimod |
Laboratoires Juvise Pharmaceuticals |
— |
| Posaconazole Accord 100 mg gastro-resistant tablets EU/1/19/1379/001-004 |
Posaconazole |
Accord Healthcare S.L.U. |
— |
| Posaconazole AHCL 40 mg/ml oral suspension EU/1/19/1380/001 |
Posaconazole |
Accord Healthcare S.L.U. |
— |
| Posaconazole Clonmel 100 mg gastro-resistant tablets PA0126/307/001 |
Posaconazole |
Clonmel Healthcare Ltd |
Marketed |
| Posaconazole Teva 100 mg gastro-resistant tablets PA1986/091/001 |
Posaconazole |
Teva B.V. |
Marketed |
| Posaconazole Viatris 100 mg gastro-resistant tablets PA23266/030/001 |
Posaconazole |
Viatris Limited |
Marketed |
| Posiforlid 20 mg/g eye ointment PA23081/018/001 |
Bibrocathol |
Taw Pharma (Ireland) Limited |
Not marketed |
| Potactasol 1 mg powder for concentrate for solution for infusion EU/1/10/660/001 |
Topotecan hydrochloride |
Actavis Group hf |
— |
| Potactasol 4 mg powder for concentrate for solution for infusion EU/1/10/660/002 |
Topotecan hydrochloride |
Actavis Group hf |
— |
| Potassium Chloride 0.15% w/v & Glucose 5% w/v Solution for Infusion PA2059/053/001 |
Potassium chloride, Glucose monohydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion PA2059/052/001 |
Potassium chloride, Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion - BP PA2299/010/002 |
Potassium chloride, Sodium chloride |
Baxter Holding B.V. |
Marketed |
| Potassium Chloride 0.15% w/v and Glucose 5% w/v Solution for Infusion BP PA2299/009/002 |
Potassium chloride, Glucose |
Baxter Holding B.V. |
Marketed |
| Potassium Chloride 0.15% w/v, Sodium Chloride 0.18% w/v, Glucose 4% w/v Solution for Infusion PA2299/001/002 |
Potassium chloride, Sodium chloride, Glucose anhydrous |
Baxter Holding B.V. |
Marketed |
| Potassium Chloride 0.3 % w/v and Glucose 5% w/v Solution for Infusion BP PA2299/009/001 |
Potassium chloride, Glucose (as monohydrate) |
Baxter Holding B.V. |
Marketed |
| Potassium Chloride 0.3% w/v & Glucose 5% w/v Solution for Infusion PA2059/053/002 |
Potassium chloride, Glucose monohydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion PA2059/052/002 |
Potassium chloride, Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion BP PA2299/010/001 |
Potassium chloride, Sodium chloride |
Baxter Holding B.V. |
Marketed |
| Potassium Chloride 0.3% w/v and Sodium Chloride 0.18% w/v in Glucose 4% w/v Intravenous Infusion BP (Viaflo Container) PA2299/001/001 |
Potassium chloride, Sodium chloride, Glucose monohydrate |
Baxter Holding B.V. |
Marketed |
| Potassium Chloride 15% w/v Concentrate for solution for infusion PA1122/003/001 |
Potassium chloride |
Noridem Enterprises Limited |
Not marketed |
| Potassium Chloride 15% w/v Concentrate for Solution for Infusion PA0073/106/001 |
Potassium chloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Potassium Chloride 15% w/v Concentrate for Solution for Infusion PA0179/030/002 |
Potassium chloride |
B. Braun Medical Limited |
Marketed |
| Potassium Chloride 15% w/v Concentrate for Solution for Infusion PA2059/054/001 |
Potassium chloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Potassium iodide G.L. Pharma 65 mg tablets PA1770/001/001 |
Potassium iodide |
G.L. Pharma GmbH |
Not marketed |
| Potassium Phosphate 1mmol/ml + 0.6mmol/ml Concentrate for Solution for Infusion PA0179/005/001 |
Dipotassium phosphate, Potassium dihydrogen phosphate |
B. Braun Medical Limited |
Marketed |
| POTELIGEO 4 mg/mL concentrate for solution for infusion EU/1/18/1335/001 |
MOGAMULIZUMAB |
Kyowa Kirin Holdings B.V. |
— |
| Pradaxa 110 mg coated granules EU/1/08/442/0029 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 110 mg hard capsules EU/1/08/442/5-8 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg coated granules EU/1/08/442/030 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg hard capsules EU/1/08/442/009-013 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |